KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $6.4 million.

  • Guardant Health's Change in Inventory rose 2096.35% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 48412.16%. This contributed to the annual value of $9.1 million for FY2024, which is 1173.91% down from last year.
  • Latest data reveals that Guardant Health reported Change in Inventory of $6.4 million as of Q3 2025, which was up 2096.35% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Change in Inventory registered a high of $23.3 million during Q2 2022, and its lowest value of -$15.1 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Inventory was $5.3 million (2024), whereas its average is $3.6 million.
  • Over the last 5 years, Guardant Health's Change in Inventory had its largest YoY gain of 107737.2% in 2022, and its largest YoY loss of 29293.9% in 2022.
  • Guardant Health's Change in Inventory (Quarter) stood at $5.9 million in 2021, then tumbled by 292.94% to -$11.4 million in 2022, then plummeted by 31.76% to -$15.1 million in 2023, then soared by 91.95% to -$1.2 million in 2024, then soared by 629.49% to $6.4 million in 2025.
  • Its last three reported values are $6.4 million in Q3 2025, $6.8 million for Q2 2025, and $6.2 million during Q1 2025.